Adjuvant therapy with antidepressants for the management of inflammatory bowel disease

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objectives 1. To assess the efficacy and safety of antidepressants for managing anxiety and depression in IBD 2. To assess the efficacy and safety of antidepressants for managing quality of life in IBD Secondary objectives 1. To assess the efficacy and safety of antidepressants for managing disease activity in IBD